BCDA
Biocardia Inc
NASDAQ: BCDA · HEALTHCARE · BIOTECHNOLOGY
$1.10
-3.51% today
Updated 2026-04-29
Market cap
$12.69M
P/E ratio
—
P/S ratio
2,520.59x
EPS (TTM)
$-1.23
Dividend yield
—
52W range
$1 – $3
Volume
0.1M
WallStSmart proprietary scores
14
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$15.50
+1309.09%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-2.50M
- Revenue declining -100.00% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.35M | $477000.00 | $58000.00 | $0.00 | $0.00 |
| Net income | $-11.91M | $-11.57M | $-7.95M | $-8.23M | $-1.98M |
| EPS | — | — | — | — | $-1.23 |
| Free cash flow | $-10.63M | $-9.99M | $-8.03M | $-7.44M | $-2.50M |
| Profit margin | -881.14% | -2,425.79% | -13,700.00% | — | — |
Peer comparison
Smart narrative
Biocardia Inc trades at $1.10. Our Smart Value Score of 14/100 indicates the stock is weak.
Frequently asked questions
What is Biocardia Inc's stock price?
Biocardia Inc (BCDA) trades at $1.10.
Is Biocardia Inc overvalued?
Smart Value Score 14/100 (Grade F, Strong Sell).
What is the price target of Biocardia Inc (BCDA)?
The analyst target price is $15.50, representing +1309.1% upside from the current price of $1.10.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2,520.59x
ROE-950.00%
Beta0.55
50D MA$1.21
200D MA$1.48
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—